Xuanzhu Biopharmaceutical Co., Ltd. Class H (2575) Financial Statements

1 Followers

Xuanzhu Biopharmaceutical Co., Ltd. Class H Financial Overview

Xuanzhu Biopharmaceutical Co., Ltd. Class H's market cap is currently HK$8.68B. The company's EPS TTM is HK$; its P/E ratio is -14.38; Xuanzhu Biopharmaceutical Co., Ltd. Class H is scheduled to report earnings on ―, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 24	Dec 23	Dec 22
Income Statement
Total Revenue	HK$ 32.63M	HK$ 32.04K	HK$ 0.00
Gross Profit	HK$ -12.60M	HK$ -35.52M	HK$ -30.16M
Operating Income	HK$ -611.27M	HK$ -374.71M	HK$ -580.24M
EBITDA	HK$ -566.36M	HK$ -295.28M	HK$ -563.77M
Net Income	HK$ -603.29M	HK$ -332.12M	HK$ -595.70M
Balance Sheet
Cash & Short-Term Investments	HK$ 294.13M	HK$ 495.15M	HK$ 792.98M
Total Assets	HK$ 1.27B	HK$ 1.45B	HK$ 1.63B
Total Debt	HK$ 1.57M	HK$ 18.79M	HK$ 32.82M
Net Debt	HK$ -174.87M	HK$ -138.54M	HK$ -218.80M
Total Liabilities	HK$ 255.31M	HK$ 232.05M	HK$ 130.75M
Stockholders' Equity	HK$ 1.02B	HK$ 1.22B	HK$ 1.50B
Cash Flow
Free Cash Flow	HK$ -105.22M	HK$ -130.05M	HK$ -501.15M
Operating Cash Flow	HK$ -104.67M	HK$ -128.13M	HK$ -449.15M
Investing Cash Flow	HK$ 143.04M	HK$ 49.43M	HK$ -579.14M
Financing Cash Flow	HK$ -13.47M	HK$ -10.94M	HK$ -14.14M

Currency in HKD

Xuanzhu Biopharmaceutical Co., Ltd. Class H Earnings and Revenue History

Income Statement >

Xuanzhu Biopharmaceutical Co., Ltd. Class H Debt to Assets

Balance Sheet >

Xuanzhu Biopharmaceutical Co., Ltd. Class H Cash Flow

Cash Flow >

Xuanzhu Biopharmaceutical Co., Ltd. Class H Forecast EPS vs Actual EPS

Earnings >